Medicus International has been successfully developing global communications for 30 years.
Medicus International has been successfully delivering global communications for 30 years. Our philosophy is to develop inspired strategic solutions through an understanding of market opportunity and trends, product differentiation and required target audience reach. This has established us as experts in defining global communications strategies that deliver brand success.
We believe that we have pioneered the first truly successful approach to delivering marketing solutions to international pharmaceutical clients. With dedicated client service teams based in London and New York, we have extensive experience in supporting pre-launch, launch and post-launch phases in all major therapy areas. These encompass allergy, CV disease, CNS disease (including schizophrenia and depression), diabetes, fertility, gastroenterology, infectious diseases (including HIV), oncology, osteoporosis, pain, respiratory, rheumatology, and transplantation.
Our core services include:
As part of the Publicis Healthcare Communications Group, Medicus International is supported by the largest worldwide healthcare network, including Medicus and Discovery offices and the Saatchi & Saatchi Healthcare Group.
For further details contact
Peneli Oliver, Managing Director
peneli.oliver@medicusgroup.com
Jane Smith, Director of Client Services
jane.smith@medicusgroup.com
Or visit www.medicus-international.com
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.